Jefferies upgrades Expedia stock rating on growth outlook

Jefferies upgraded Expedia to Buy and raised its price target to $300 from $240, citing a projected 20%+ EPS CAGR over a three-plus year runway and implying ~14x 2027 GAAP P/E. Expedia reported strong Q4 results with B2B revenue +24% YoY, and Jefferies highlighted 100+ bps of annual EBITDA margin expansion potential, a 90% gross profit margin and aggressive share buybacks supporting valuation upside. Morgan Stanley raised its PT to $290 (from $270) and lifted bookings/EBITDA forecasts by 4%/15%, while DA Davidson cut its PT to $260 (from $294); regulatory scrutiny over pricing algorithms and Middle East-related headline risk temper the near-term upside.

Analysis

Expedia’s structural levers — margin improvement and aggressive capital returns — increase EPS convexity but also concentrate downside: buybacks reduce float and amplify earnings-per-share sensitivity to demand shocks, turning what looks like steady growth into higher beta equity on geopolitical or cyclical weakness. The migration of mix toward B2B distribution de-risks seasonality but raises counterparty and contract-concentration exposure; a few large supplier/platform deals can swing take-rates +/-100–200bps in a single year.

Second-order winners if Expedia executes on margins are payments and cloud partners (smaller incremental gross margin to Expedia means outsized operating leverage to these vendors), while metasearch and affiliate channels face margin pressure as Expedia internalizes distribution and increases direct capture. Airlines and package operators are ambivalent — higher OTA pricing can raise supplier revenues but could also accelerate direct-booking or loyalty pushes that erode OTA share over 12–36 months.

Key near-term catalysts are earnings beats driven by mix and continued buyback cadence, and headline shocks from geopolitics; both act on different horizons — headlines can knock shares 10–30% within days, while buyback-driven EPS compounding and multiple re-rating play out over 6–24 months. The main structural risks are (1) intensified regulatory scrutiny of pricing algorithms that could force disclosure or behavioral remedies compressing take-rates by tens of bps over years, and (2) AI-driven metasearch/aggregation that reduces distribution margins within 12–36 months.

The trade decision should therefore separate directional exposure to travel demand from idiosyncratic payout and regulatory risk. Short-duration hedges and relative-value pairings versus pure-growth travel peers offer cleaner exposure to buyback/margin upside while capping losses from headline-driven drawdowns.

Key Decisions for Investors

• Long EXPE via a 9–12 month bull-call spread (size 2–3% NAV): buy a longer-dated call and sell a higher strike to cap cost. R/R: target 30–50% upside in 9–12 months if EPS and margin beats persist; max loss = premium paid (low). Use this to capture buyback/margin convexity while limiting capital at risk.
• Relative-value pair — long EXPE vs short BKNG (equal notional) for 6–12 months to isolate buyback/margin alpha: idea captures Expedia-specific payout and margin execution while hedging broad travel demand moves. R/R: seek 15–25% relative outperformance; risk: sector-wide positive macro surprises lift both names and negate the spread.
• Tactical protection: buy a 3–6 month EXPE put spread (cap cost) sized to cover 30% of position notional, funded by selling short-dated calls (2–4 weeks). Purpose: limit pain from sudden geopolitical or regulatory headlines that can produce >20% moves in days; cost net-neutral to modest debit.
• If regulatory risk intensifies, rotate core exposure into travel-adjacent infrastructure (payment processors, cloud infra) via selective longs (size 1–2% NAV) for 12–24 months — these capture second-order benefits of higher travel spend without distribution regulatory beta. R/R: lower downside volatility than owning OTAs outright; risk: slower upside if OTA multiple re-rates rapidly.